ArticleVeterinary research communications2025
First report of visceral Leishmaniasis in abandoned dogs of the urban area in the central region of Colombia.
Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leishmaniasis is a significant zoonosis, with dogs serving as reservoirs and sand flies as vectors. This survey aimed to identify, for the first time, visceral Leishmaniasis (VL) in dogs in an urban shelter in the Andean region of Colombia. We sampled dogs at four longitudinal time points. We used the rKDDR-plus immunochromatographic test (ICT-rKDDR-plus) and the rKDDR-plus enzyme-linked immunosorbent assay (ELISA-rKDDR-plus) for serological diagnosis. For PCR diagnosis, we used a real-time reaction to amplify the GAPDH gene, and a conventional reaction to amplify the RV1-RV2 genes to identify the Leishmania genus. We also used multiplex PCRs to amplify five genes from Leishmania species for genotyping. Seropositivity in both tests showed 25.3% and 37.5% in dogs from the first and second collections, respectively. These animals also presented clinical and laboratory findings consistent with visceral Leishmaniasis (VL). Following GAPDH gene RT-PCR, we confirmed the amplification of 20 samples, and two samples tested positive for Leishmania spp. using the RV1-RV2 PCR method, the same samples tested positive for L. infantum using multiplex genotyping PCR. The product of the RV1-RV2 PCR exhibited 99.0% similarity to L. infantum following sequencing. These results suggest the presence of VL diagnoses, as determined by serology and PCR methods, in urban areas of the Andean region of Colombia.
Indexed as
Identifiers
41026299What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.